ImmuCell plans second expansion in three years as demand grows
ImmuCell has had a backlog of orders for its flagship product, First Defense. “Good problem to have,” says the company’s CEO.
Daniel Catlin Kristi Kenney Richard Mcgoldrick Michael Brigham Drug Administration Properties Management
Source: mainebiz.biz